|
1
|
De Velasco G, Je Y, Bossé D, Awad MM, Ott
PA, Moreira RB, Schutz F, Bellmunt V, Sonpavde GP, Hodi FS and
Choueiri TK: Comprehensive meta-analysis of key immune-related
adverse events from CTLA-4 and PD-1/PD-L1 inhibitors in cancer
patients. Cancer Immunol Res. 5:312–318. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Postow MA, Sidlow R and Hellmann MD:
Immune-related adverse events associated with immune checkpoint
blockade. N Engl J Med. 378:158–168. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gandhi L, Rodríguez-Abreu D, Gadgeel S,
Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ,
Powell SF, et al: Pembrolizumab plus chemotherapy in metastatic
non-small-cell lung cancer. N Engl J Med. 378:2078–2092.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yuan M, Huang LL, Chen JH, Wu J and Xu Q:
The emerging treatment landscape of targeted therapy in
non-small-cell lung cancer. Signal Transduct Target Ther.
4(61)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wang H, Guo X, Zhou J, Li Y, Duan L, Si X
and Zhang L, Liu X, Wang M, Shi J and Zhang L: Clinical diagnosis
and treatment of immune checkpoint inhibitor-associated
pneumonitis. Thorac Cancer. 11:191–197. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cadranel J, Canellas A, Matton L, Darrason
M, Parrot A, Jean-Marc N, Lavolé A, Anne-Marie R and Fallet V:
Pulmonary complication for immune checkpoint inhibitors in patient
with nonsmall cell lung cancer. Eur Respir Revc.
28(190058)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ma K, Lu Y, Jiang S, Tang J, Li X and
Zhang Y: The relative risk and incidence of immune checkpoint
inhibitors related pneumonitis in patients with advanced cancer: A
meta-analysis. Front Pharmacol. 9(1430)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Topalian SL, Hodi FS, Brahmer JR,
Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD,
Sosman JA, Atkins MB, et al: Safety, activity, and immune
correlates of anti-pd-1 antibody in cancer. N Engl J Med.
366:2443–2454. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Naidoo J, Page DB, Li BT, Connell LC,
Schindler K, Lacouture ME, Postow MA and Wolchok JD: Toxicities of
the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Annals
of Oncology. Ann Oncol. 26:2375–2391. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Brahmer JR, Lacchetti C, Schneider BJ,
Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner
JM, Thompson JA, et al: Management of immune-related adverse events
in patients treated with immune checkpoint inhibitor therapy:
American society of clinical oncology clinical practice guideline.
J Clin Oncol. 36:1714–1768. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Petri CR, Patell R, Batalini F, Rangachari
D and Hallowell RW: Severe pulmonary toxicity from immune
checkpoint inhibitor treated successfully with intravenous
immunoglobulin: Case report and review of the literature. Respir
Med Case Rep. 27(100834)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Stuck AE, Minder CE and Frey FJ: Risk of
infectious complications in patients taking glucocorticosteroids.
Rev Infect Dis. 11:954–963. 1989.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fishman JA: Opportunistic
infections-coming to the limits of immunosuppression. Cold Spring
Harb Perspect Med. 3(a015669)2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Konoplev S, Champlin RE, Giralt S, Ueno
NT, Khouri I, Raad I and Whimbey E: Cytomegalovirus pneumonia in
adult autologous blood and marrow transplant recipients. Bone
Marrow Transplantationc. 27:877–881. 2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Travi G and Pergam SA: Cytomegalovirus
pneumonia in hematopoietic stem cell recipients. J Intensive Care
Med. 29:200–212. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Franquet T, Lee KS and Müller NL:
Thin-section CT findings in 32 immunocompromised patients with
Cytomegalovirus pneumonia who do not have AIDS. Am J Roentgenol.
181:1059–1063. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kang EY, Patz EF Jr and Müller NL:
Cytomegalovirus pneumonia in transplant patients: CT findings. J
Comput Assist Tomogr. 20:295–299. 1996.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ljungman P, Boeckh M, Hirsch HH, Josephson
F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V and
Griffiths PD: Definitions of cytomegalovirus infection and disease
in transplant patients for use in clinical trials. Clin Infect Dis.
64:87–91. 2017.PubMed/NCBI View Article : Google Scholar
|
